Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1963 1
1964 5
1966 4
1967 3
1968 5
1969 3
1970 10
1971 4
1972 5
1973 12
1974 7
1975 7
1976 8
1977 13
1978 5
1979 9
1980 7
1981 3
1982 7
1983 14
1984 5
1985 6
1986 8
1987 23
1988 12
1989 12
1990 12
1991 4
1992 6
1993 9
1994 13
1995 8
1996 7
1997 11
1998 7
1999 26
2000 22
2001 15
2002 22
2003 30
2004 32
2005 21
2006 28
2007 36
2008 23
2009 37
2010 45
2011 56
2012 64
2013 67
2014 58
2015 65
2016 64
2017 65
2018 69
2019 74
2020 85
2021 88
2022 76
2023 100
2024 68

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,455 results

Results by year

Filters applied: . Clear all
Page 1
Randomized phase III study of gemcitabine, cisplatin plus S-1 versus gemcitabine, cisplatin for advanced biliary tract cancer (KHBO1401- MITSUBA).
Ioka T, Kanai M, Kobayashi S, Sakai D, Eguchi H, Baba H, Seo S, Taketomi A, Takayama T, Yamaue H, Takahashi M, Sho M, Kamei K, Fujimoto J, Toyoda M, Shimizu J, Goto T, Shindo Y, Yoshimura K, Hatano E, Nagano H; Kansai Hepatobiliary Oncology Group (KHBO). Ioka T, et al. Among authors: nagano h. J Hepatobiliary Pancreat Sci. 2023 Jan;30(1):102-110. doi: 10.1002/jhbp.1219. Epub 2022 Aug 9. J Hepatobiliary Pancreat Sci. 2023. PMID: 35900311 Free PMC article. Clinical Trial.
International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study.
Pagès F, Mlecnik B, Marliot F, Bindea G, Ou FS, Bifulco C, Lugli A, Zlobec I, Rau TT, Berger MD, Nagtegaal ID, Vink-Börger E, Hartmann A, Geppert C, Kolwelter J, Merkel S, Grützmann R, Van den Eynde M, Jouret-Mourin A, Kartheuser A, Léonard D, Remue C, Wang JY, Bavi P, Roehrl MHA, Ohashi PS, Nguyen LT, Han S, MacGregor HL, Hafezi-Bakhtiari S, Wouters BG, Masucci GV, Andersson EK, Zavadova E, Vocka M, Spacek J, Petruzelka L, Konopasek B, Dundr P, Skalova H, Nemejcova K, Botti G, Tatangelo F, Delrio P, Ciliberto G, Maio M, Laghi L, Grizzi F, Fredriksen T, Buttard B, Angelova M, Vasaturo A, Maby P, Church SE, Angell HK, Lafontaine L, Bruni D, El Sissy C, Haicheur N, Kirilovsky A, Berger A, Lagorce C, Meyers JP, Paustian C, Feng Z, Ballesteros-Merino C, Dijkstra J, van de Water C, van Lent-van Vliet S, Knijn N, Mușină AM, Scripcariu DV, Popivanova B, Xu M, Fujita T, Hazama S, Suzuki N, Nagano H, Okuno K, Torigoe T, Sato N, Furuhata T, Takemasa I, Itoh K, Patel PS, Vora HH, Shah B, Patel JB, Rajvik KN, Pandya SJ, Shukla SN, Wang Y, Zhang G, Kawakami Y, Marincola FM, Ascierto PA, Sargent DJ, Fox BA, Galon J. Pagès F, et al. Among authors: nagano h. Lancet. 2018 May 26;391(10135):2128-2139. doi: 10.1016/S0140-6736(18)30789-X. Epub 2018 May 10. Lancet. 2018. PMID: 29754777
[Tumor Immunogenicity and Immune Checkpoint Inhibitors].
Nakajima M, Tsunedomi R, Shindo Y, Tokumitsu Y, Matsui H, Watanabe Y, Tomochika S, Yoshida S, Iida M, Suzuki N, Takeda S, Ioka T, Hazama S, Nagano H. Nakajima M, et al. Among authors: nagano h. Gan To Kagaku Ryoho. 2022 Sep;49(9):922-927. Gan To Kagaku Ryoho. 2022. PMID: 36156006 Review. Japanese.
Novel Biomarkers for Personalized Cancer Immunotherapy.
Shindo Y, Hazama S, Tsunedomi R, Suzuki N, Nagano H. Shindo Y, et al. Among authors: nagano h. Cancers (Basel). 2019 Aug 22;11(9):1223. doi: 10.3390/cancers11091223. Cancers (Basel). 2019. PMID: 31443339 Free PMC article. Review.
Transanal TME: new standard or fad?
Hasegawa S, Yoshida Y, Morimoto M, Kojima D, Komono A, Aisu N, Taketomi H, Nagano H, Matsumoto Y, Munechika T, Kajitani R. Hasegawa S, et al. Among authors: nagano h. J Anus Rectum Colon. 2019 Jan 29;3(1):1-9. doi: 10.23922/jarc.2018-030. eCollection 2019. J Anus Rectum Colon. 2019. PMID: 31559361 Free PMC article. Review.
[Cancer Vaccine Focused on Neoantigens].
Shindo Y, Hazama S, Nagano H. Shindo Y, et al. Among authors: nagano h. Gan To Kagaku Ryoho. 2019 Sep;46(9):1367-1371. Gan To Kagaku Ryoho. 2019. PMID: 31530772 Review. Japanese.
Dysphonia in Polymyositis/Dermatomyositis in Adults.
Nagano H, Matsumoto H, Kurono Y. Nagano H, et al. Indian J Otolaryngol Head Neck Surg. 2023 Jun;75(2):760-764. doi: 10.1007/s12070-022-03240-9. Epub 2023 Jan 12. Indian J Otolaryngol Head Neck Surg. 2023. PMID: 37274997 Free PMC article.
Flower in the duodenum (with video).
Hamabe K, Nishikawa J, Goto A, Ogawa R, Hashimoto S, Hoshii Y, Iida M, Nagano H, Takami T. Hamabe K, et al. Among authors: nagano h. Gastrointest Endosc. 2022 Aug;96(2):383-384. doi: 10.1016/j.gie.2022.04.058. Epub 2022 Apr 28. Gastrointest Endosc. 2022. PMID: 35489395 No abstract available.
Expansion of CD4+ cytotoxic T lymphocytes with specific gene expression patterns may contribute to suppression of tumor immunity in oral squamous cell carcinoma: single-cell analysis and in vitro experiments.
Chen H, Sameshima J, Yokomizo S, Sueyoshi T, Nagano H, Miyahara Y, Sakamoto T, Fujii S, Kiyoshima T, Guy T, Nakamura S, Moriyama M, Kaneko N, Kawano S. Chen H, et al. Among authors: nagano h. Front Immunol. 2023 Nov 23;14:1305783. doi: 10.3389/fimmu.2023.1305783. eCollection 2023. Front Immunol. 2023. PMID: 38077321 Free PMC article.
1,455 results